Search
Now showing items 1-10 of 16
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
(University of Nairobi, 2004)
Volunteer Recruitment for phase 1 HIV Vaccine Trials in Nairobi
(University of Nairobi, 2002)
Safety Issues, DNA & MVA HIV Vaccine Trials at KAVI Oral presentation
(University of Nairobi, 2003-01)
The Use of Viral Peptides as a Quality Control for ELISPOT Assays in HIV-1 Vaccine Trials in Kenya
(University of Nairobi,, 2004)
Abstract no. A10065"
Incubation Time to Symptomatic Disease (SD) and AIDS in Women with a Known Duration of Infection.
(University of Nairobi, 1991)
CD4+ and CD8+lymphocyte distribution among healthy Kenyans
(University of Nairobi, 2004)
VCT program in Kenya – are we making progress?
(University of Nairobi, 2006)
CD4 and CD8 T - Lymphocyte distribution amoung healthy Kenyans enrolling in an HIV vaccine trial
(University of Nairobi,, 2004)
Abstract no. ThPeA7001"